Brief: A1M: ROSGard shows renal protective effect during radiation therapy

Disruptive Pharma AB (publ)

09/12/2016 13:58

Dec 9 (Reuters) - A1M Pharma AB  A1M.ST : 
    * Announces that the active substance in the company's candidate drug ROSGard shows a strong 
renal protective effect in connection with radiation therapy (PRRT) in a short-term preclinical 
study with an animal model 
    * Results of the effect 6 months after treatment are expected by the end of Q1 2017 
 
 Source text: http://bit.ly/2hbcBhL 
     
 Further company coverage:  A1M.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))